p53 regulates mitochondrial function and alpha-synuclein aggregation in Parkinson's disease
Journal of Biological Chemistry · 2026-07 · 302 (7) · 113184
DOI: 10.1016/j.jbc.2026.113184 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-07. Verfasst von Kaiying Hou und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Henan University, Kaifeng, China. Hauptthemen laut MEDLINE: alpha-Synuclein, Tumor Suppressor Protein p53, Mitochondria, Parkinson Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Department of Science and Technology of Henan Province, Henan Province Natural Science Foundation.
Abstract (Originalsprache)
Parkinson's disease (PD) is the second most common neurodegenerative disease, in which mitochondrial dysfunction and abnormal aggregation of alpha-synuclein (α-syn) play key roles in the pathology of PD. As a classic tumor suppressor, p53 has also been found to be involved in the pathological process of PD in recent years. However, the specific mechanism by which p53 regulates mitochondrial function and abnormal aggregation of α-syn is still unclear. Here, we observed that the expression of α-syn and p53 was increased and mitochondria were impaired in the MPTP-induced PD mouse model, leading us to speculate on whether p53 affects mitochondrial impairment and abnormal α-syn aggregation in PD pathology. Next, cellular experiments revealed that the p53 inhibition by pifithrin-α regulates mitochondrial function through mitophagy and mitochondrial dynamics, then ameliorates oxidative stress and apoptosis in PD. Meanwhile, the in vitro study showed that the p53 protein interacted with α-syn to accelerate the process of α-syn liquid-liquid phase separation and amyloid fibril formation, promoting the development of PD pathology. In summary, p53 modulates mitochondrial function through mitophagy and mitochondrial dynamics, stimulating the pathogenic aggregation of α-syn protein and neurodegeneration in Parkinson's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Henan University, Kaifeng, China.
- Pharmaceutical College, Henan University, Kaifeng, China.
- Translational Neuromedicine and Neurourology Center, Huaihe Hospital of Henan University, Kaifeng, China.
- Pharmaceutical College, Henan University, Kaifeng, China. Electronic address: lihong@vip.henu.edu.cn.
- School of Life Sciences, Henan University, Kaifeng, China; Translational Neuromedicine and Neurourology Center, Huaihe Hospital of Henan University, Kaifeng, China. Electronic address: jswei@henu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Department of Science and Technology of Henan Province
- Henan Province Natural Science Foundation
Zitieren
APA
Hou, K., Chen, J., Xie, Y., Liu, T., Li, J., Meng, C., Niu, D., Xian, M., Li, J., Zhu, C., Li, H., & Wei, J. (2026). p53 regulates mitochondrial function and alpha-synuclein aggregation in Parkinson's disease. Journal of Biological Chemistry, 302(7), 113184. https://doi.org/10.1016/j.jbc.2026.113184
Vancouver
Hou K, Chen J, Xie Y, Liu T, Li J, Meng C, et al. p53 regulates mitochondrial function and alpha-synuclein aggregation in Parkinson's disease. Journal of Biological Chemistry. 2026;302(7):113184. doi:10.1016/j.jbc.2026.113184
BibTeX
@article{Hou2026,
author = {Hou, Kaiying and Chen, Jialin and Xie, Yuxin and Liu, Tingting and Li, Jiaying and Meng, Chong and Niu, Dongxue and Xian, Meiyan and Li, Jingwen and Zhu, Chaoyang and Li, Hong and Wei, Jianshe},
title = {p53 regulates mitochondrial function and alpha-synuclein aggregation in Parkinson's disease},
journal = {Journal of Biological Chemistry},
year = {2026},
volume = {302},
number = {7},
pages = {113184},
doi = {10.1016/j.jbc.2026.113184}
}
EUVIMED